Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools

Neurogastroenterology and Motility

Volumn 19, Issue 4, 2007, Pages 318-326

  Sudo, H ^a   Ozaki, K ^a   Muramatsu, H ^a   Kamei, K ^a   Yogo, K ^a   Cynshi, O ^a   Koga, H ^a   Itoh, Z ^b   Omura, S ^c   Takanashi, H ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Constipation; Defecation; Diarrhoea; GM 611; Mitemcinal; Motilin

Indexed keywords

HORMONE RECEPTOR STIMULATING AGENT; MITEMCINAL; MORPHINE; MOTILIN; SENNOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DIARRHEA; DOG; DOSE RESPONSE; FEMALE; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; LOOSE FECES; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; WATER CONTENT;

ANIMALS; CONSTIPATION; DEFECATION; DIARRHEA; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; GASTROINTESTINAL AGENTS; MORPHINE; MOTILIN; RABBITS; REFERENCE VALUES;

EID: 33947515694     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00885.x     Document Type: Article

References (40)

1. Perdue C. Managing constipation in advanced cancer care. Nurs Times 2005; 101: 36-40.
2. Bleser S, Brunton S, Carmichael B, Olden K, Rasch R, Steege J. Management of chronic constipation: Recommendations from a consensus panel. J Fam Pract 2005; 54: 691-8.
3. Koch TR. Constipation. In: Haubrich WS, Schaffner F eds. Bockus Gastroenterology 5th edn. Vol. I. Philadelphia, PA: WB Saunders 1995: 102-12.
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
5. Sasaki K, Yamauchi K, Kuwano S. Metabolic activation of sennoside A in mice. Planta Med 1979; 37: 370-8.
6. Corazziari E, Materia E, Bausano G et al. Laxative consumption in chronic nonorganic constipation. J Clin Gastroenterol 1987; 9: 427-30.
7. Duncan A, Morris AJ, Cameron A, Stewart MJ, Brydon WG, Russell RI. Laxative induced diarrohea - a neglected diagnosis. J R Soc Med 1992; 85: 203-5.
8. Itoh Z. Motilin and clinical application. Peptides 1997; 18: 593-608.
9. Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 1984; 247: G688-94.
10. Tomomasa T, Kuroume T, Arai H, Wakabayashi K, Itoh Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986; 31: 157-61.
11. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 1886-99.
12. Bradette M, Poitras P, Boivin M. Effect of motilin and erythromycin on the motor activity of the human colon. J Gastrointest Motil 1993; 5: 247-51.
13. Sharma SS, Bhargava N, Mathur SC. Effect of oral erythromycin on colonic transit in patients with idiopathic constipation: a pilot study. Dig Dis Sci 1995; 40: 2446-9.
14. Shibata C, Sasaki I, Naito H et al. Effect of motilin on colonic motor activity in the interdigestive state in conscious dogs. Tohoku J Exp Med 1995; 176: 53-60.
15. Chiba T, Thomforde GM, Kost LJ, Allen RG, Phillips SF. Motilides accelerate regional gastrointestinal transit in the dog. Aliment Pharmacol Ther 2000; 14: 955-60.
16. Costa A, De Ponti F, Gibelli G, Crema F, D'Angelo L. In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit. Pharmacology 1997; 54: 64-75.
17. Faghih R, Nellans HN, Plattner JJ. Motilides and motilactides: design and development of motilin receptor agonists as a new class of gastrointestinal prokinetic drugs. Drugs Future 1998; 23: 861-72.
18. Ōmura S, Tsuzuki K, Sunazuka T et al. Macrolides with gastrointestinal motor stimulating activity. J Med Chem 1987; 30: 1941-3.
19. Koga H, Sato T, Tsuzuki K, Onoda H, Kuboniwa H, Takanashi H. Potent, acid-stable and orally active macrolidetype motilin receptor agonists, GM-611 and the derivatives. Bioorg Med Chem Lett 1994; 4: 1347-52.
20. Koga H, Takanashi H, Itoh Z, Ōmura S. Design, SAR and pharmacology of GM-611, the first acid-stable nonpeptide motilin receptor agonist. Drugs Future 2002; 27: 255-72.
21. Fang J, McCallum R, DiBase J, Schmitt CM, Kipnes MK. Effects of mitemcinal fumarate (GM-611) on gastric emptying inpatients with idiopathic or diabetic gastroparesis. Gastroenterology 2004; 126: A483.
22. Kipnes MS, Schmitt CM, DiBaise JK, Fang JC, Sarosiek I. Safety of mitemcinal fumarate (GM-611) in patients with symptomatic gastroparesis. Diabetes 2004; 53: A132.
23. Depoortere I, Peeters TL, Vantrappen G. Motilin receptors of the rabbit colon. Peptides 1991; 12: 89-94.
24. Hasler WL, Heldsinger A, Owyang C. Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors. Am J Physiol 1992; 262: G50-5.
25. 2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 2001; 13: 27-35.
26. Miller P, Trudel L, St-Pierre S, Takanashi H, Poitras P. Neural and muscular receptors for motilin in the rabbit colon. Peptides 2000; 21: 283-7.
27. Schang JC, Hemond M, Hebert M, Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci 1986; 38: 671-6.
28. Ferraz AA, Cowles VE, Condon RE, Schulte WJ. Opioid and nonopioid analgesic drug effects on colon contractions in monkeys. Dig Dis Sci 1995; 40: 1417-9.
29. Ito H, Kiso T, Yuki H et al. Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets. Eur J Pharmacol 2001; 424: 151-7.
30. McKay JS, Linaker BD, Higgs NB and Turnberg LA. Studies of the antisecretory activity of morphine in rabbit ileum in vitro. Gastroenterology 1982; 82: 243-7.
31. Walsh TD. Oral morphine in chronic cancer pain. Pain 1984; 18: 1-11.
32. Glare P, Lickiss JN. Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster. J Pain Symptom Manage 1992; 7: 369-71.
33. Takanashi H, Yogo K, Ozaki K et al. GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. J Pharmacol Exp Ther 1995; 273: 624-8.
34. Peeters TL, Bormans V, Vantrappen G. Regional and temporal variations of motilin receptor density in the human and rabbit gastrointestinal tract. Dig Dis Sci 1985; 30: 787.
35. Ozaki K, Sudo H, Muramatsu H et al. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs. Inflammopharmacology 2007; 15: 36-42.
36. Talley NJ, Verlinden M, Snape W et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000; 14: 1653-61.
37. Thielemans L, Depoortere I, Perret J et al. Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 2005; 313: 1397-405.
38. Park M-I, Ferber I, Camilleri M et al. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006; 18: 28-36.
39. Jameson JS, Rogers J, Misiewicz JJ, Raimundo AH, Henry MM. Oral or intravenous erythromycin has no effect on human distal colonic motility. Aliment Pharmacol Ther 1992; 6: 589-95.
40. Bassotti G, Chiarioni G, Vantini I, Morelli A, Whitehead WE. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. Z Gastroenterol 1998; 36: 209-13.